** Hong Kong-listed shares of WuXi Biologics jump 8.3% to HK$20.30, and are third-biggest pct gainers in the benchmark Hang Seng Index
** WuXi Biologics and WuXi AppTec are planning to sell some of their operations after the Chinese biotech companies were targeted by the U.S. on national security grounds, the Financial Times reported on Thursday
** WuXi Biologics and WuXi AppTec did not immediately respond to Reuters' requests for a comment
** The U.S. House of Representatives passed a bill last month aiming to restrict business with China's WuXi AppTec and several other biotech companies on national security grounds
** Hong Kong stock of WuXi AppTec jumps 7.3% to HK$64.55, and is fourth-biggest pct gainer in Hang Seng Index
, which is up 0.4%
** Hang Seng Commerce & Industry Index gains 0.8%, and healthcare index rises 1.7%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Comments